Disorders in the course of tissue insulin resistance and an increase in peripheral and hepatic insulin secretion also lead to atherogenic dyslipidemia and the release of pro-inflammatory factors, vasoactive factors, and thrombogenic factors, which promote the development of hypertension and cardiovascular disease [68]. The gene discussed is INS; the disease is Insulin resistance.